Clinical and Mechanistic Findings from MOTIF Trial: A Phase 2 Study Using Food Allergen Oral Immunotherapy for Cashew or Shrimp Allergy

Oral immunotherapy
DOI: 10.1016/j.jaci.2023.11.230 Publication Date: 2024-02-05T09:45:06Z